Trial intelligence / Profile preview

Testosterone therapy in men with pulmonary hypertension

2005-000049-12Phase 2Completed

Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Start
Feb 2005
Modality
Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of Sustanon 250 in pulmonary hypertension (PH), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in functional capacity. Started Feb 2005; status: completed.

02

Drugs

Sustanon 250
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on 2005-000049-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000049-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call